GENESIS IBRC INDIA

BSE: 514336 12 Sep 2025

Healthcare

₹ 38.04

GENESIS IBRC INDIA LIMITED specializes in Biotechnology within the Healthcare sector.

GENESIS IBRC INDIA

BSE: 514336 12 Sep 2025

Healthcare

₹ 38.04

GENESIS IBRC INDIA LIMITED specializes in Biotechnology within the Healthcare sector.

Book Value

6.56

Dividend Yield

0.0%

Debt to Equity

0.0

Stock P/E

18.1

Market Cap

63.1 Cr

GENESIS IBRC INDIA - Share Price & Details

Market Cap

₹63.1

High /Low

48.5 / 15.8

Stock P/E

18.1

Book Value

₹6.56

Dividend Yield

0.0

ROCE

51.6

ROE

₹51.6

Face Value

10.0

PEG Ratio

0.08

EVEBITDA

₹18.1

Debt

0.00

CMP / FCF

-2,103

Debt to equity

₹0.0

NP Ann

3.50

High price all time

48.5

Piotroski score

₹5.0

Graham Number

19.9

No. Eq. Shares

1.3

Net CF

₹0.00

Net profit

3.48

Price to book value

7.4

Interest Coverage

₹NA

Low price all time

2.01

Industry PE

65.0

Reserves

₹-4.47

Free Cash Flow

₹0.00

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
FABINO ENTERPRISES LIMITED	NA	NA	NA	NA	5.46	91.0
Triochem Products Ltd.,	NA	NA	NA	NA	0
GENESIS IBRC INDIA LIMITED	NA	NA	NA	NA	63.1	18.1
GODAVARI DRUGS LTD.	NA	NA	NA	NA	61.3	16.2
VASUNDHARA RASAYANS LTD	NA	NA	NA	NA	60	15.2

Peer Comparison Chart

About GENESIS IBRC INDIA

GENESIS IBRC INDIA LIMITED, with Security Code 514336, is a leading player in the Biotechnology industry, categorized under the Healthcare sector, offering Equity instruments.

Latest News

Genesis IBRC India Achieves 52-Week High Amid Strong Market Performance Trends

(10 Sep 2025)

Genesis IBRC India, a microcap in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs. 46.22 on September 10, 2025.

Genesis IBRC India Achieves 52-Week High Amid Strong Sector Performance

(10 Sep 2025)

Genesis IBRC India, a microcap in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs. 44.02 on September 9, 2025.

Genesis IBRC India Achieves 52-Week High Amidst Market Strength and Erratic Trading

(08 Sep 2025)

Genesis IBRC India, a microcap in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs. 41.93 on September 8, 2025.

Genesis IBRC Achieves 52-Week High, Signaling Strong Market Position Amid Fluctuations

(05 Sep 2025)

Genesis IBRC India, a microcap in the Pharmaceuticals & Biotechnology sector, reached a 52-week high of Rs. 39.94 on September 5, 2025.

Genesis IBRC Achieves 52-Week High Amid Strong Market Activity and Sector Outperformance

(20 Aug 2025)

Genesis IBRC India, a microcap in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week high of Rs. 38.04, reflecting a strong performance...

Q1 Results Today: Ashok Leyland, Vodafone Idea, Glenmark, Patanjali, IOC & Over 600 Companies To Announce

(14 Aug 2025)

In what is set to be a hectic day on Dalal Street, over 650 listed companies are slated to report their first-quarter (Q1 FY26) financial...

Quarterly Table

Standalone

Metrics	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Expenses	0.0	0.1	0.1	0.0	0.0	3.7	0.1	0.0	0.0	0.0
Operating Profit	0.0	-0.1	-0.1	0.0	0.0	-3.7	-0.1	0.0	0.0	0.0
OPM %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Other Income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0
Interest	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Depreciation	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Profit before tax	0.0	-0.1	-0.1	0.0	0.0	-3.7	-0.1	3.6	0.0	0.0
Tax %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Profit	0.0	-0.1	-0.1	0.0	0.0	-3.7	-0.1	3.6	0.0	0.0
EPS in Rs	-0.02	-0.04	-0.05	-0.02	-0.02	-2.84	-0.07	2.81	-0.2	0

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	0%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	-13%

Stock Price CAGR
10 Years:	3%
5 Years:	21%
3 Years:	25%
1 Year:	47%

Compounded Sales Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	0%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	0%

Stock Price CAGR
10 Years:	3%
5 Years:	21%
3 Years:	25%
1 Year:	47%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

Stock Mutual Funds Data

Loading technicals…

Moving Averages

Latest Close: — • Records Used: — • Last Trading Date: —

Simple Moving Averages (SMA)

Period	SMA Value	Status

Exponential Moving Averages (EMA)

Period	EMA Value	Status

Oscillators

Key Oscillators

latest calculation

Indicator	Value

GENESIS IBRC INDIA

GENESIS IBRC INDIA

GENESIS IBRC INDIA - Share Price & Details

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About GENESIS IBRC INDIA

Latest News

Genesis IBRC India Achieves 52-Week High Amid Strong Market Performance Trends

Genesis IBRC India Achieves 52-Week High Amid Strong Sector Performance

Genesis IBRC India Achieves 52-Week High Amidst Market Strength and Erratic Trading

Genesis IBRC Achieves 52-Week High, Signaling Strong Market Position Amid Fluctuations

Genesis IBRC Achieves 52-Week High Amid Strong Market Activity and Sector Outperformance

Q1 Results Today: Ashok Leyland, Vodafone Idea, Glenmark, Patanjali, IOC & Over 600 Companies To Announce

Shares Below Rs 100: Only Buyers Were Seen In These Stocks, Locked in Upper Circuit Today

Is Genesis IBRC India Limited (514336) a Good Long Term Bet - Overwhelming financial success

What analysts say about QETH stock - Rapid growth trajectories

When is BLDE stock expected to show significant growth - Free Market Dynamics Reports

What institutional investors are buying SNDL Inc. stock - Superior investment outcomes

Should I hold or sell Enpro Inc. stock in 2025 - Market-leading growth rates

What is ONEOK Inc. company’s growth strategy - Build wealth steadily with proven stock picks

How strong is CRESW company’s balance sheet - Free Stock Movement Tracking

How volatile is ITRM stock compared to the market - Consistently superior profits

Genesis IBRC India Limited (514336) Gets Regulatory Approval - Exceptional growth trajectory

What institutional investors are buying MDJM Ltd stock - Beginner Investor Guidance For 2025

How strong is GNFT company’s balance sheet - Skyrocketing returns

What are the technical indicators suggesting about CPS Technologies Corporation - Daily Trading Report For Consistent Profits

WTBA Stock Analysis and Forecast - Rapidly expanding wealth

Disha Resources Limited (531553) Quarterly Results Are Out - High-yield market plays

What analysts say about bioAffinity Technologies Inc. Equity Warrant stock - Superior profit margins

CBAN Stock Analysis and Forecast - Superior capital gains

Is Genesis IBRC India Limited (514336) a Good Long Term Bet - Free Stock Chart Pattern Guide

High Potential Indian Stocks to Buy Exclusive Stock Club Picks - Exponential wealth increase

Best Infrastructure Stocks in India Group Insights For Smart Investments - High-performance investment picks

Genesis IBRC Achieves 52-Week High Amid Broader Market Decline

Is Imperial Oil Limited a good long term investment - Robust investment performance

Genesis IBRC India Limited (514336) Signs Major Deal - Phenomenal returns

Genesis IBRC India Reaches All-Time High, Signaling Strong Market Momentum in Pharmaceuticals

Is Genesis IBRC India Limited (514336) a Good Long Term Bet - Explosive market performance

Genesis IBRC India Achieves 52-Week High Amid Strong Market Sentiment

Genesis IBRC India Limited (514336) Hits 52 Week High - Superior trading gains

Genesis IBRC India Limited (514336) Signs Major Deal - Phenomenal trading returns

Genesis IBRC India Limited (514336) Gets Regulatory Approval - Free Capital Efficiency Planning

Genesis IBRC India Limited (514336) Hits 52 Week High - High-octane investment gains

What analysts say about BML.PRL stock - Unmatched market gains

Genesis IBRC Reaches New High Amid Broader Market Gains and Erratic Trading Patterns

The Anup Engineering Limited (542460) to Launch New Product Line - Record-setting profit potential

Best Stocks for Risk Averse Investors in India Low Risk Stock Alerts - Outstanding capital returns

Biofil Chemicals and Pharmaceuticals Limited (524396) vs yyy - Unprecedented profits

Is Genesis IBRC India Limited (514336) a Good Long Term Bet - Rapid wealth multiplication

Equippp Social Impact Technologies Limited (EQUIPPP) Stock Experiences Sudden Dip - Rapid market gains

Genesis IBRC India Limited (514336) Gets Regulatory Approval - Phenomenal capital gains

Is Genesis IBRC India Limited (514336) a Good Long Term Bet - Consistent double returns

Reliable Ventures India Limited (532124) Expands into New Market - Exceptional stock performance

What drives CDLX stock price - Phenomenal capital gains

What analysts say about LNKB stock - High-margin investment plays

Understanding the Impact of Social Media on Indian Stock Trends Financial Expert Recommendations - Rapid growth trajectories

Genesis IBRC India Achieves 52-Week High Amid Broader Market Decline

Genesis IBRC Stock Reaches All-Time High, Signaling Strong Market Momentum

Genesis IBRC India Reaches 52-Week High Amid Broader Market Decline

Genesis IBRC India Achieves All-Time High Stock Price Amid Strong Sector Performance

Genesis IBRC India Ltd Achieves New 52-Week High Amid Strong Buying Activity

Q4 results today: Ola Electric, Mazagon Dock, Suzlon Energy, Bajaj Auto & 552 others to declare earnings on May 29

মাত্র ২৭ টাকার স্টক দিচ্ছে ২৫০% রিটার্ন? রকেট গতিতে বাজার কাঁপাচ্ছে এই শেয়ার

India's Axis Bank reports higher profit as lending income rises

Axis Bank's Consolidated Net Profit Declines in Fiscal Q4; Shares Down 4%

Penny Stock: Got 250% return in one year, share price is just ₹27

Penny Stock:एक साल में मिला है 250% तक रिटर्न, शेयर की कीमत बस ₹27 है

Axis Bank Approves Raising Of Funds Worth Up To 200 Bln Rupees Via Equity

India's Axis Bank beats quarterly profit view, sees improved retail loan growth in FY26

पैनी स्टॉक: सिर्फ ₹27 में शेयर, एक साल में दिया 250% रिटर्न

Penny Stock: एक साल में मिला है 250% तक रिटर्न, बस 27 रुपए है शेयर की कीमत

Axis Bank To Consider Option Of Raising Funds

India's Axis Bank, J.P. Morgan roll out anytime dollar payments for clients

Axis Bank Is Said To Weigh Majority Stake Sale Of $1 Billion Shadow Bank Unit - Bloomberg News

Genesis IBRC India reports standalone net loss of Rs 0.03 crore in the December 2024 quarter

Q3 Results: RVNL, EaseMyTrip, MTNL, Aditya Birla Fashion And Others To Announce Earnings Today; Full List Here

Genesis IBRC India Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024

Genesis IBRC India reports standalone net profit of Rs 3.65 crore in the September 2024 quarter